Pharma News
-
{
- All
- News
- Videos
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
The bigger picture threatens a move away from established production hubs like India.
-
India Pharmaceutical Sector Aims To Make India A Global Innovation Hub In 2026
New Delhi, March 30 (IANS) India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based growth to value and rese
-
Iran War Impact: Hospital Bills, Medicines Could Soon Cost More In India
India's medical devices and pharma sectors import a large share of raw materials, active ingredients and specialised components
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
Pakistan Faces Critical Medicine Shortage Amid Import Disruptions, Only 45 Days Of Supply Remain
Pakistan faces critical medicine shortages as Middle East conflict disrupts imports of pharmaceutical raw materials and essential supplies.
-
Sensex Opens Nearly 200 Points Lower, Nifty In Red Too
Sectorally, Nifty Auto, Bank, Financial Services, FMCG, Metal, Pharma, Realty, Oil & Gas opened in red.
-
Corporate India To See 9.1% Salary Hike In 2026: Report
Corporate India is expected to roll out an average salary increase of 9.1 per cent in 2026, with Global Capability Centres (GCCs) leading the growth in pay, a new report said on Monday.
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
Textiles, Gems, Pharma: Sectors To Be Impacted By India-US Trade Deal
Sectors such as gems and jewelry, textiles, fisheries, and chemicals are likely to react positively in the market following the India-US trade deal.
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
The bigger picture threatens a move away from established production hubs like India.
-
India Pharmaceutical Sector Aims To Make India A Global Innovation Hub In 2026
New Delhi, March 30 (IANS) India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based growth to value and rese
-
Iran War Impact: Hospital Bills, Medicines Could Soon Cost More In India
India's medical devices and pharma sectors import a large share of raw materials, active ingredients and specialised components
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
Pakistan Faces Critical Medicine Shortage Amid Import Disruptions, Only 45 Days Of Supply Remain
Pakistan faces critical medicine shortages as Middle East conflict disrupts imports of pharmaceutical raw materials and essential supplies.
-
Sensex Opens Nearly 200 Points Lower, Nifty In Red Too
Sectorally, Nifty Auto, Bank, Financial Services, FMCG, Metal, Pharma, Realty, Oil & Gas opened in red.
-
Corporate India To See 9.1% Salary Hike In 2026: Report
Corporate India is expected to roll out an average salary increase of 9.1 per cent in 2026, with Global Capability Centres (GCCs) leading the growth in pay, a new report said on Monday.
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
Textiles, Gems, Pharma: Sectors To Be Impacted By India-US Trade Deal
Sectors such as gems and jewelry, textiles, fisheries, and chemicals are likely to react positively in the market following the India-US trade deal.
